The OncoAlert Network 🚨
@oncoalert.bsky.social
🌐 Worldwide Network of Oncology Professionals & Patient Advocates with the common goal of ending cancer, we are Oncology360 degrees 🌎 We are #OncoAlert 🚨
www.OncoAlert360.com
www.OncoAlert360.com
MEDiscussion at #SABCS25 🚨Join top global experts for a high-level exchange on the latest in HER2+, HR+/luminal disease, and ctDNA. 👉 www.medsir.org/events/medtalk
🎙 Chairs: Dr. Javier Cortés, Dr. Antonio Llombart, Dr. Naoto Ueno
🗣 Moderator: Dr. Giampaolo Bianchini
🎙 Chairs: Dr. Javier Cortés, Dr. Antonio Llombart, Dr. Naoto Ueno
🗣 Moderator: Dr. Giampaolo Bianchini
November 24, 2025 at 7:17 PM
MEDiscussion at #SABCS25 🚨Join top global experts for a high-level exchange on the latest in HER2+, HR+/luminal disease, and ctDNA. 👉 www.medsir.org/events/medtalk
🎙 Chairs: Dr. Javier Cortés, Dr. Antonio Llombart, Dr. Naoto Ueno
🗣 Moderator: Dr. Giampaolo Bianchini
🎙 Chairs: Dr. Javier Cortés, Dr. Antonio Llombart, Dr. Naoto Ueno
🗣 Moderator: Dr. Giampaolo Bianchini
Our Collaborators at @mirrorsmed would like to Invite you to Join The Global Forum on GU Oncology info here👉 buff.ly/QJgM3QV
December 3-6, 2025 in Lisbon🇵🇹or ONLINE as this is a HYBRID meeting.
OncoAlert 🚨Will be live on location
#ProstateCancer #BladderCancer #KidneyCancer
December 3-6, 2025 in Lisbon🇵🇹or ONLINE as this is a HYBRID meeting.
OncoAlert 🚨Will be live on location
#ProstateCancer #BladderCancer #KidneyCancer
November 19, 2025 at 4:14 PM
Our Collaborators at @mirrorsmed would like to Invite you to Join The Global Forum on GU Oncology info here👉 buff.ly/QJgM3QV
December 3-6, 2025 in Lisbon🇵🇹or ONLINE as this is a HYBRID meeting.
OncoAlert 🚨Will be live on location
#ProstateCancer #BladderCancer #KidneyCancer
December 3-6, 2025 in Lisbon🇵🇹or ONLINE as this is a HYBRID meeting.
OncoAlert 🚨Will be live on location
#ProstateCancer #BladderCancer #KidneyCancer
Join @Achard_Verane and @BertrandTOMBAL for this Manuscript2Practice series on postoperative #ProstateCancer recurrence ⭐️WATCH HERE👉 mirrorsmed.org/m2p-postoper...
brought to you by our collaborators at @mirrorsmed
brought to you by our collaborators at @mirrorsmed
November 17, 2025 at 4:25 PM
Join @Achard_Verane and @BertrandTOMBAL for this Manuscript2Practice series on postoperative #ProstateCancer recurrence ⭐️WATCH HERE👉 mirrorsmed.org/m2p-postoper...
brought to you by our collaborators at @mirrorsmed
brought to you by our collaborators at @mirrorsmed
Our Collaborators at @mirrorsmed would like to Invite you to Join The Global Forum on GU Oncology info here👉https://gu-global-forum.org
December 3-6, 2025 in Lisbon🇵🇹or ONLINE as this is a HYBRID meeting.
OncoAlert 🚨Will be live on location
#ProstateCancer #BladderCancer #KidneyCancer
December 3-6, 2025 in Lisbon🇵🇹or ONLINE as this is a HYBRID meeting.
OncoAlert 🚨Will be live on location
#ProstateCancer #BladderCancer #KidneyCancer
November 13, 2025 at 3:55 PM
Our Collaborators at @mirrorsmed would like to Invite you to Join The Global Forum on GU Oncology info here👉https://gu-global-forum.org
December 3-6, 2025 in Lisbon🇵🇹or ONLINE as this is a HYBRID meeting.
OncoAlert 🚨Will be live on location
#ProstateCancer #BladderCancer #KidneyCancer
December 3-6, 2025 in Lisbon🇵🇹or ONLINE as this is a HYBRID meeting.
OncoAlert 🚨Will be live on location
#ProstateCancer #BladderCancer #KidneyCancer
Straight from #UromigosLive 2025
A GREAT discussion on ADC use in #BladderCancer
The possibility of Combination Trials, seeing the trade off between Toxicity and the Long Term Benefit
Complete Video Here x.com/Uromigos/sta...
A GREAT discussion on ADC use in #BladderCancer
The possibility of Combination Trials, seeing the trade off between Toxicity and the Long Term Benefit
Complete Video Here x.com/Uromigos/sta...
November 8, 2025 at 8:09 PM
Straight from #UromigosLive 2025
A GREAT discussion on ADC use in #BladderCancer
The possibility of Combination Trials, seeing the trade off between Toxicity and the Long Term Benefit
Complete Video Here x.com/Uromigos/sta...
A GREAT discussion on ADC use in #BladderCancer
The possibility of Combination Trials, seeing the trade off between Toxicity and the Long Term Benefit
Complete Video Here x.com/Uromigos/sta...
Dear Colleagues in #ESMO25
Our Collaborators at @mirrorsmed would like to Invite you to Join The Global Forum on GU Oncology info here👉https://gu-global-forum.org
December 3-6, 2025 in Lisbon🇵🇹or ONLINE as this is a HYBRID meeting.
OncoAlert 🚨will be Live from Lisbon covering this Great meeting
Our Collaborators at @mirrorsmed would like to Invite you to Join The Global Forum on GU Oncology info here👉https://gu-global-forum.org
December 3-6, 2025 in Lisbon🇵🇹or ONLINE as this is a HYBRID meeting.
OncoAlert 🚨will be Live from Lisbon covering this Great meeting
November 7, 2025 at 1:47 PM
Dear Colleagues in #ESMO25
Our Collaborators at @mirrorsmed would like to Invite you to Join The Global Forum on GU Oncology info here👉https://gu-global-forum.org
December 3-6, 2025 in Lisbon🇵🇹or ONLINE as this is a HYBRID meeting.
OncoAlert 🚨will be Live from Lisbon covering this Great meeting
Our Collaborators at @mirrorsmed would like to Invite you to Join The Global Forum on GU Oncology info here👉https://gu-global-forum.org
December 3-6, 2025 in Lisbon🇵🇹or ONLINE as this is a HYBRID meeting.
OncoAlert 🚨will be Live from Lisbon covering this Great meeting
Join us for a discussion on rPFS as a surrogate for OS in mHSPC #ProstateCancer
Available now 👉 mirrorsmed.org/m2p-rpfs-sur...
What does it mean for clinical practice? How should it guide treatment decisions?
📺 Join Neal Shore, MD & Alicia Morgans, MD
Available now 👉 mirrorsmed.org/m2p-rpfs-sur...
What does it mean for clinical practice? How should it guide treatment decisions?
📺 Join Neal Shore, MD & Alicia Morgans, MD
November 7, 2025 at 1:41 PM
Join us for a discussion on rPFS as a surrogate for OS in mHSPC #ProstateCancer
Available now 👉 mirrorsmed.org/m2p-rpfs-sur...
What does it mean for clinical practice? How should it guide treatment decisions?
📺 Join Neal Shore, MD & Alicia Morgans, MD
Available now 👉 mirrorsmed.org/m2p-rpfs-sur...
What does it mean for clinical practice? How should it guide treatment decisions?
📺 Join Neal Shore, MD & Alicia Morgans, MD
Join Vérane Achard and Bertrand Timbal for this Manuscript2Practice series on postoperative #ProstateCancer recurrence 👉 mirrorsmed.org/m2p-postoper...
brought to you by our collaborators at Mirrors of Medicine.
brought to you by our collaborators at Mirrors of Medicine.
November 1, 2025 at 10:37 AM
Join Vérane Achard and Bertrand Timbal for this Manuscript2Practice series on postoperative #ProstateCancer recurrence 👉 mirrorsmed.org/m2p-postoper...
brought to you by our collaborators at Mirrors of Medicine.
brought to you by our collaborators at Mirrors of Medicine.